Harris Associates’s QIAGEN NV QGENF Stock Holding History

Harris Associates’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,737,240	Closed	-$48.7M	–	126
2016 Q4	$48.7M	Sell	1,737,240 -759,500	-30%	-$21.3M	0.09%	97
2016 Q3	$68.5M	Sell	2,496,740 -835,200	-25%	-$22.9M	0.14%	95
2016 Q2	$72.7M	Buy	3,331,940 +1,282,240	+63%	+$28M	0.15%	94
2016 Q1	$45.8M	Buy	2,049,700 +1,792,900	+698%	+$40.1M	0.09%	101
2015 Q4	$7.1M	Buy	+256,800	New	+$7.1M	0.01%	117

Other funds holding QGENF

BJCM

Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return

Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Harris Associates's QGENF Position: Q1 2017 in Review

Harris Associates sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 1,737,240 shares — an estimated $48.7M sold.

Harris Associates first reported a position in QGENF in Q4 2015 and held it in 5 quarters. The position peaked at $72.7M in Q2 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

Harris Associates reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
Harris Associates sold 1,737,240 QIAGEN NV shares in Q1 2017, an estimated $48.7M.
Harris Associates first reported a position in QIAGEN NV in Q4 2015 and held it in 5 quarters.
Harris Associates's QIAGEN NV position peaked at $72.7M in Q2 2016.
6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Harris Associates's 13F filing for Q1 2017, filed 8 May 2017.